P-fimbriae in the presence of anti-PapA antibodies: New insight of antibodies action against pathogens

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Mortezaei, Narges ^a   Singh, Bhupender ^a   Bullitt, Esther ^b   Uhlin, Bernt Eric ^a   Andersson, Magnus ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ATPA PROTEIN, E COLI; ESCHERICHIA COLI PROTEIN; FIMBRIA PROTEIN;

BACTERIUM ADHERENCE; EPITHELIUM CELL; ESCHERICHIA COLI; FIMBRIA; IMMUNOLOGY; MICROBIOLOGY; PROTEIN SECONDARY STRUCTURE; URINARY TRACT INFECTION;

ANTIBODIES; BACTERIAL ADHESION; EPITHELIAL CELLS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FIMBRIAE PROTEINS; FIMBRIAE, BACTERIAL; PROTEIN STRUCTURE, SECONDARY; URINARY TRACT INFECTIONS;

EID: 84889054525     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03393     Document Type: Article

References (47)

1. Kucheria, R., Dasgupta, P., Sacks, S. H., Khan,M. S. & Sheerin, N. S. Urinary tract infections: new insights into a common problem. Postgrad. Med. J. 81, 83-6 (2005).
2. Duncan, M. J. et al.. The distinct binding specificities exhibited by enterobacterial type 1 fimbriae are determined by their fimbrial shafts. J. Biol. Chem. 280, 37707-16 (2005).
3. Miller, E., Garcia, T., Hultgren, S. J. & Oberhauser, A. F. The mechanical properties of E. coli type 1 pili measured by atomic force microscopy techniques. Biophys. J. 91, 3848-56 (2006).
4. Thomas, W. E. Catch Bonds in Adhesion. Annu. Rev. Biomed. Eng. 10, 39-57 (2008).
5. Zakrisson, J., Wiklund, K., Axner, O. &Andersson, M. Helix-like biopolymers can act as dampers of force for bacteria in flows. Eur. Biophys. J. 41, 551-60 (2012).
6. Zakrisson, J., Wiklund, K., Axner, O. & Andersson, M. The shaft of the type 1 fimbriae regulates an externalforce to match the FimH catch bond. Biophys. J. 104, 2137-2148 (2013).
7. Li, Y.-F. et al.. Structure of CFA/I fimbriae from enterotoxigenic Escherichia coli. Proc. Natl. Acad. Sci. 106, 10793-8 (2009).
8. Poole, S. T. et al.. Donor strand complementation governs intersubunit interaction of fimbriae of the alternate chaperone pathway. Mol. Microbiol. 63, 1372-84 (2007).
9. Klinth, J. E. et al.. Impairment of the biomechanical compliance of P pili: a novel means of inhibiting uropathogenic bacterial infections? Eur. Biophys. J. 41, 285-95 (2012).
10. Sirigu, P., Perra, M. T., Turno, F. & Usai, E. Immunohistochemical demonstration of secretory IgA in human urothelium. Histol. Histopathol. 10, 645-50 (1995).
11. Hjelm, E., Forsum, U. & Frodin, L. Significance of urinary immunoglobulins in tests for antibody-coated bacteria. J. Clin. Pathol. 32, 1206-1210 (1979).
12. Giamarellou, H. Antibody-coated bacteria in urine: when, where and why? J. Antimicrob. Chemother. 13, 95-99 (1984).
13. Kantele, A. et al.. Local immune response to upper urinary tract infections in children. Clin. Vaccine Immunol. CVI 15, 412-7 (2008).
14. Svanborg-Ede?, C. & Svennerholm, a, M. Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells. Infect. Immun. 22, 790-7 (1978).
15. Underdown, B. J. & Schiff, J.M. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu. Rev. Immunol. 4, 389-417 (1986).
16. Langermann, S. Prevention of Mucosal Escherichia coli Infection by FimHAdhesin-Based Systemic Vaccination. Science 276, 607-611 (1997).
17. Langermann, S. et al.. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J. Infect. Dis. 181, 774-8 (2000).
18. Langermann, S. & Ballou, W. R. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections. J. Infect. Dis. 183 Suppl, S84-6 (2001).
19. Roberts, J. a. et al.. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein. J. Urol. 171, 1682-5 (2004).
20. Rene, P., Dinolfo,M. & Silverblatt, F. J. Serum and urogenital antibody responses to Escherichia coli pili in cystitis. Infect. Immun. 38, 542-7 (1982).
21. Rene, P. & Silverblatt, F. J. Serological response to Escherichia coli pili in Serological Response to Escherichia coli Pili in Pyelonephritis. Infection 37, 749 (1982).
22. Salit, I. E., Hanley, J., Clubb, L. & Fanning, S. The human antibody response to uropathogenic Escherichia coli: a review. Can. J. Infect. Dis. 34, 312-8 (1988).
23. Andersson, M., Fa?lman, E., Uhlin, B. E. & Axner, O. A sticky chain model of the elongation and unfolding of Escherichia coli P pili under stress. Biophys. J. 90, 1521-34 (2006).
24. Ba?ga, M., Go?ansson, M., Normark, S. & Uhlin, B. E. Processed mRNA with differential stability in the regulation of E. coli pilin gene expression. Cell 52, 197-206 (1988).
25. Jass, J. et al.. Physical properties of Escherichia coli P pili measured by optical tweezers. Biophys. J. 87, 4271-83 (2004).
26. Andersson, M., Axner, O., Almqvist, F., Uhlin, B. E. & Fa?lman, E. Physical properties of biopolymers assessed by optical tweezers: analysis of folding and refolding of bacterial pili. ChemPhysChem 9, 221-35 (2008).
27. Andersson, M., Uhlin, B. E. & Fa?lman, E. The biomechanical properties of E. coli pili for urinary tract attachment reflect the host environment. Biophys. J. 93, 3008-14 (2007).
28. Bjo?nham, O., Axner, O. & Andersson, M. Modeling of the elongation and retraction of Escherichia coli P pili under strain by Monte Carlo simulations. Eur. Biophys. J. 37, 381-91 (2008).
29. Mu, X.-Q. & Bullitt, E. Structure and assembly of P-pili: a protruding hinge region used for assembly of a bacterial adhesion filament. Proc. Natl. Acad. Sci. 103, 9861-6 (2006).
30. O'Hanley, P., Lark, D., Falkow, S. & Schoolnik, G. Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis. J. Clin. Invest. 75, 347-60 (1985).
31. Melican, K. et al.. Uropathogenic Escherichia coli P and Type 1 fimbriae act in synergy in a living host to facilitate renal colonization leading to nephron obstruction. PLoS Pathog. 7, e1001298 (2011).
32. Wullt, B., Bergsten, G., Samuelsson, M. & Svanborg, C. The role of P fimbriae for Escherichia coli establishment and mucosal inflammation in the human urinary tract. Int. J. Antimicrob. Agents. 19, 522-538 (2002).
33. Bergsten, G., Wullt, B. & Svanborg, C. Escherichia coli, fimbriae, bacterial persistence and host response induction in the human urinary tract. nt. J. Med. Microbiol. 295, 487-502 (2005).
34. Lane, M. C. & Mobley, H. L. T. Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. Kidney Int. 72, 19-25 (2007).
35. Marshall, B. T., Sarangapani, K. K., Lou, J., McEver, R. P. & Zhu, C. Force history dependence of receptor-ligand dissociation. Biophys. J. 88, 1458-66 (2005).
36. Weisel, J. W., Shuman, H. & Litvinov, R. Protein-protein unbinding induced by force: single-molecule studies. Curr. Opin. Struct. Biol. 13, 227-235 (2003).
37. Andersson, M., Fa?lman, E., Uhlin, B. E. & Axner, O. Dynamic force spectroscopy of E. coli P pili. Biophys. J. 91, 2717-25 (2006).
38. Goransson, M., Forsman, K. & Uhlin, B. E. Regulatory genes in the thermoregulation of Escherichia coli pili gene transcription. Genes Dev. 3, 123-130 (1989).
39. Guyer, M. S., Reed, R. E., Steitz, T. & Low, K. B. Identification of a sex-factoraffinity site in E. coli as gamma delta. Cold Spring Harbor Symp. Quant. Biol. 45, 135-140 (1981).
40. Nakao, R., Ramstedt, M.,Wai, S. N.&Uhlin, B. E. Enhanced Biofilm Formation by Escherichia coli LPSMutants Defective inHep Biosynthesis. PLOS ONE 7, e51241 (2012).
41. Paracuellos, P., Ohman, A., Sauer-Eriksson, a, E. & Uhlin, B. E. Expression and purification of SfaX(II), a protein involved in regulating adhesion and motility genes in extraintestinal pathogenic Escherichia coli. PREP 86, 127-34 (2012).
42. Tolic?N?relykke, S. F. et al.. Calibration of optical tweezers with positional detection in the back focal plane. Rev. Sci. Instrum. 77, 103101 (2006).
43. Andersson, M., Czerwinski, F. & Oddershede, L. B. Optimizing active and passive calibration of optical tweezers. J. Opt. 13, 044020 (2011).
44. Fa?lman, E., Schedin, S., Jass, J., Andersson, M. & Uhlin, B. E. Optical tweezers based force measurement system for quantitating binding interactions: system design and application for the study of bacterial adhesion. Biosens. Bioelectron. 19, 1429-1437 (2004).
45. Roux, K. H., Strelets, L., Brekke, O. H., Sandlie, I.&Michaelsen, T. E. Comparisons of the ability of human IgG3 hinge mutants, IgM, IgE, and IgA2, to form small immune complexes: a role for flexibility and geometry. J. Immunol. 161, 4083-90 (1998).
46. Janeway, A. C., Travers, P.,Walport, M. & Shlomchik, J. M. Immunobiology, 5th edition-The Immune System in Health and Disease. (Garland publishing: New York, 2001).
47. Pettersen, E. F. et al.. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-12 (2004).